357 related articles for article (PubMed ID: 20494109)
1. Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge.
Björkhem I; Hansson M
Biochem Biophys Res Commun; 2010 May; 396(1):46-9. PubMed ID: 20494109
[TBL] [Abstract][Full Text] [Related]
2. Cerebrotendinous xanthomatosis.
Björkhem I
Curr Opin Lipidol; 2013 Aug; 24(4):283-7. PubMed ID: 23759795
[TBL] [Abstract][Full Text] [Related]
3. On the mechanism of accumulation of cholestanol in the brain of mice with a disruption of sterol 27-hydroxylase.
Båvner A; Shafaati M; Hansson M; Olin M; Shpitzen S; Meiner V; Leitersdorf E; Björkhem I
J Lipid Res; 2010 Sep; 51(9):2722-30. PubMed ID: 20511491
[TBL] [Abstract][Full Text] [Related]
4. A case of cerebrotendinous xanthomatosis with massive xanthomas but without a considerable increase in serum cholestanol levels.
Takahashi M; Okazaki H; Tada H; Ishibashi S
J Clin Lipidol; 2023; 17(6):834-838. PubMed ID: 37777472
[TBL] [Abstract][Full Text] [Related]
5. On the substrate specificity of human CYP27A1: implications for bile acid and cholestanol formation.
Norlin M; von Bahr S; Bjorkhem I; Wikvall K
J Lipid Res; 2003 Aug; 44(8):1515-22. PubMed ID: 12777473
[TBL] [Abstract][Full Text] [Related]
6. Sterol 27-hydroxylase deficiency: a rare cause of xanthomas in normocholesterolemic humans.
Björkhem I; Leitersdorf E
Trends Endocrinol Metab; 2000 Jul; 11(5):180-3. PubMed ID: 10856919
[TBL] [Abstract][Full Text] [Related]
7. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Tint GS
Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
[TBL] [Abstract][Full Text] [Related]
8. Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX.
Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Leitersdorf E; Tint GS; Erickson SK; Tanaka N; Shefer S
J Lipid Res; 2001 Feb; 42(2):291-300. PubMed ID: 11181760
[TBL] [Abstract][Full Text] [Related]
9. Late-onset Cerebrotendinous Xanthomatosis with a Novel Mutation in the CYP27A1 Gene.
Sasamura A; Akazawa S; Haraguchi A; Horie I; Ando T; Abiru N; Takei H; Nittono H; Une M; Kurosawa T; Murai T; Naruse H; Nakayama T; Kotani K; Remaley AT; Kawakami A
Intern Med; 2018 Jun; 57(11):1611-1616. PubMed ID: 29434128
[TBL] [Abstract][Full Text] [Related]
10. [Laboratory diagnosis of a rare congenital neurodegenerative disease: cerebrotendinous xanthomatosis].
Varga VE; Katkó M; Harangi J; Balogh I; Kapás I; Madar L; Seres I; Molnár MJ; Paragh G; Kovács GG; Harangi M
Orv Hetil; 2014 May; 155(21):811-6. PubMed ID: 24836315
[TBL] [Abstract][Full Text] [Related]
11. A Rare Case of Cerebrotendinous Xanthomatosis Associated With a Mutation on COG8 Gene.
Ghoshouni H; Sarmadian R; Irilouzadian R; Biglari HN; Gilani A
J Investig Med High Impact Case Rep; 2023; 11():23247096231168109. PubMed ID: 37083278
[TBL] [Abstract][Full Text] [Related]
12. Clinical report: A patient with a late diagnosis of cerebrotendinous xanthomatosis and a response to treatment.
Alhariri A; Hamilton K; Oza V; Cordoro K; Sobreira NL; Malloy M; Slavotinek A
Am J Med Genet A; 2017 Aug; 173(8):2275-2279. PubMed ID: 28590052
[TBL] [Abstract][Full Text] [Related]
13. A case of Cerebrotendinous Xanthomatosis with spinal cord involvement and without tendon xanthomas: identification of a new mutation of the CYP27A1 gene.
Gelzo M; Di Taranto MD; Bisecco A; D'Amico A; Capuano R; Giacobbe C; Caputo M; Cirillo M; Tedeschi G; Fortunato G; Corso G
Acta Neurol Belg; 2021 Apr; 121(2):561-566. PubMed ID: 31875301
[TBL] [Abstract][Full Text] [Related]
14. Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds.
Moghadasian MH
Clin Invest Med; 2004 Feb; 27(1):42-50. PubMed ID: 15061585
[TBL] [Abstract][Full Text] [Related]
15. Apparent underdiagnosis of Cerebrotendinous Xanthomatosis revealed by analysis of ~60,000 human exomes.
Appadurai V; DeBarber A; Chiang PW; Patel SB; Steiner RD; Tyler C; Bonnen PE
Mol Genet Metab; 2015 Dec; 116(4):298-304. PubMed ID: 26643207
[TBL] [Abstract][Full Text] [Related]
16. Additional pathways of sterol metabolism: Evidence from analysis of Cyp27a1-/- mouse brain and plasma.
Griffiths WJ; Crick PJ; Meljon A; Theofilopoulos S; Abdel-Khalik J; Yutuc E; Parker JE; Kelly DE; Kelly SL; Arenas E; Wang Y
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Feb; 1864(2):191-211. PubMed ID: 30471425
[TBL] [Abstract][Full Text] [Related]
17. Isolation of 5 alpha-cholestane-3 beta, 7 alpha-diol from bile of patients with cerebrotendinous xanthomatosis. Inefficiency of this steroid as a precursor to cholestanol.
Björkhem I; Buchmann MS; Skrede S
Biochim Biophys Acta; 1983 Sep; 753(2):220-6. PubMed ID: 6412759
[TBL] [Abstract][Full Text] [Related]
18. Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports.
Di Taranto MD; Gelzo M; Giacobbe C; Gentile M; Marotta G; Savastano S; Dello Russo A; Fortunato G; Corso G
Metab Brain Dis; 2016 Oct; 31(5):1185-8. PubMed ID: 27225395
[TBL] [Abstract][Full Text] [Related]
19. Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene.
Rosen H; Reshef A; Maeda N; Lippoldt A; Shpizen S; Triger L; Eggertsen G; Björkhem I; Leitersdorf E
J Biol Chem; 1998 Jun; 273(24):14805-12. PubMed ID: 9614081
[TBL] [Abstract][Full Text] [Related]
20. Two novel mutations in the sterol 27-hydroxylase gene causing cerebrotendinous xanthomatosis.
Lamon-Fava S; Schaefer EJ; Garuti R; Salen G; Calandra S
Clin Genet; 2002 Mar; 61(3):185-91. PubMed ID: 12000359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]